dosimetry:instructions_for_use:instructions_for_use
Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
dosimetry:instructions_for_use:instructions_for_use [2015/07/02 15:32] – created dpatenaude | dosimetry:instructions_for_use:instructions_for_use [2021/07/29 18:23] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 7: | Line 7: | ||
The intended use for this application is to aid software developers in implementing programs that contain functionality similar to radiation treatment planning systems (TPS), including programs designed to provide independent secondary checks of other TPS results. Therefore typical indications for use are for planning or analyzing proton radiation therapy treatments for cancer patients with a wide range of disease locations. This is the context in which this application was developed and it was within this scope of use that the system was tested and cleared for sale by the FDA. | The intended use for this application is to aid software developers in implementing programs that contain functionality similar to radiation treatment planning systems (TPS), including programs designed to provide independent secondary checks of other TPS results. Therefore typical indications for use are for planning or analyzing proton radiation therapy treatments for cancer patients with a wide range of disease locations. This is the context in which this application was developed and it was within this scope of use that the system was tested and cleared for sale by the FDA. | ||
- | ===== Warning ===== | ||
- | Since this application is intended to be used primarily by other software developers in a possible wide range of TPS-like applications, | ||
- | |||
- | <wrap em> | ||
===== User Profile ===== | ===== User Profile ===== | ||
- | As stated, this application is not intended to be a direct end-user facing program; therefore it will not be used by the average medical dosimetrist for day-to-day planning needs. Rather, the application will be used by experienced computer programmers, | + | As stated, this application is not intended to be a direct end-user facing program; therefore it will not be used by the average medical dosimetrist for day-to-day planning needs. Rather, the application will be used by experienced computer programmers, |
+ | |||
+ | ===== User Testing Responsibilities ===== | ||
+ | |||
+ | It is the user's responsibility to commission and test the dose accuracy prior to patient treatment. This general liability on the end users should be understood and communicated to all users and a representative with signatory authority from each facility using Astroid must sign a //User Agreement// stating their understanding and acceptance of this responsibility. | ||
+ | |||
+ | Additionally, | ||
+ | |||
+ | ===== Clinical Safety ===== | ||
+ | |||
+ | It is the responsibility of the user to perform end-to-end testing prior to the clinical implementation of Astroid. The user should follow accepted industry guideline (such as AAPM TG244) for the end-to-end testing. This testing should be performed by qualified personnel. | ||
+ | |||
+ | It is the responsibility of the facility to ensure that all users of the Astroid treatment planning system have had training on the Astroid product and possess the appropriate clinical education, experience, and (where applicable) licensure to develop clinical treatment plans. This includes, but is not limited to, the application training provided by Astroid staff. | ||
+ | |||
+ | It is recommended that users follow acceptable global standards during the commissioning of the Astroid product. During the clinical set up, the following should be tested to ensure clinical safety prior to treatment: | ||
+ | - Geometric relationships of the hardware machine models | ||
+ | - The dose algorithm | ||
+ | - Data access and storage | ||
+ | - Accuracy of the planning dose systems. | ||
+ | |||
+ | ===== Warning ===== | ||
+ | |||
+ | It is critical that all users read these Instructions for Use and the User Guide material carefully and completely and consult the provided User Guides and other training materials to ensure proper use of the application and proper interpretation of results. Additionally, | ||
+ | |||
+ | <WRAP center round important 60%> | ||
+ | Prior to the delivery of any plan on a patient, users are responsible for performing patient specific QA to ensure clinical acceptability of the delivered dose distribution. Since users are responsible for testing the acceptability of the delivered dose before treatment, Astroid, its staff, and representatives shall not be liable for any mis-treatments that may result from use of the system. | ||
+ | </ | ||
- | ===== Testing Responsibilities ===== | + | <wrap em> |
- | Refer to the [[commissioning_guide: | ||
==== Derived Applications ==== | ==== Derived Applications ==== | ||
Line 49: | Line 70: | ||
==== Proton Treatment Delivery Machine Model ==== | ==== Proton Treatment Delivery Machine Model ==== | ||
- | The current state of proton delivery machines is such that two major modes of delivery are utilized: spread-out Bragg peak (SOBP) and pencil-beam scanning (PBS). Each such mode requires various machine parameters to be defined which facilitate the proper modeling of the dose delivered by a beam. Providing a means for users to specify the parameters necessary to configure their system is therefore an important concern so that the dose calculation algorithms can provide proper results for users of a variety of proton machine vendors. The proton treatment machine model provides user configurable parameters that allow dose calculation results to be commissioned to a variety of proton machine types, | + | The current state of proton delivery machines is such that two major modes of delivery are utilized: spread-out Bragg peak (SOBP) and pencil-beam scanning (PBS). Each such mode requires various machine parameters to be defined which facilitate the proper modeling of the dose delivered by a beam. Providing a means for users to specify the parameters necessary to configure their system is therefore an important concern so that the dose calculation algorithms can provide proper results for users of a variety of proton machine vendors. The proton treatment machine model provides user configurable parameters that allow dose calculation results to be commissioned to a variety of proton machine types, |
---- | ---- | ||
<WRAP center 10%>// | <WRAP center 10%>// | ||
- | <WRAP center | + | <WRAP center |
dosimetry/instructions_for_use/instructions_for_use.1435851134.txt.gz · Last modified: 2021/07/29 18:21 (external edit)